Similar Papers

Paper Title
Journal
Date
Author
Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral Vectors
Arkasubhra Ghosh ... Dongsheng Duan
Molecular Therapy | VOL. 15
Arkasubhra Ghosh, et. al.Arkasubhra Ghosh ... Dongsheng Duan
01 Apr 2007
Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1
Zarife Sahenk ... Jerry R Mendell
Molecular Therapy - Methods & Clinical Development | VOL. 22
Zarife Sahenk, et. al.Zarife Sahenk ... Jerry R Mendell
24 Jun 2021
Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies.
Meredith K James ... Lindsay N Alfano
Physical Therapy | VOL. 102
Meredith K James, et. al.Meredith K James ... Lindsay N Alfano
06 Aug 2022
Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy
Yongping Yue ... Dongsheng Duan
Expert Opinion on Orphan Drugs | VOL. 4
Yongping Yue, et. al.Yongping Yue ... Dongsheng Duan
17 Dec 2015
View more papers

More From: Neuromuscular Disorders

Paper Title
Journal
Date
Author
CMT2 and distal hereditary motor neuropathy associated with VRK1 variants: case series
Sasha A Živković ... Daniel Dicapua
Neuromuscular Disorders | VOL. 47
Sasha A Živković, et. al.Sasha A Živković ... Daniel Dicapua
01 Feb 2025
Management of presymptomatic juvenile patients with Late-Onset Pompe Disease (LOPD)
M Porcino ... A Toscano
Neuromuscular Disorders | VOL. -
M Porcino, et. al.M Porcino ... A Toscano
01 Jan 2025
MRC CENTRE NEUROMUSCULAR DISEASE BIOBANK LONDON: ITS ROLE IN THE ADVANCEMENT OF RARE AND NEUROMUSCULAR DISEASES RESEARCH
Pierpaolo Ala ... Jennifer Morgan
Neuromuscular Disorders | VOL. -
Pierpaolo Ala, et. al.Pierpaolo Ala ... Jennifer Morgan
01 Jan 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B)
Bettina C Henzi ... Dirk Fischer
Neuromuscular Disorders | VOL. -
Bettina C Henzi, et. al.Bettina C Henzi ... Dirk Fischer
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.